体内研究 (In Vivo) |
Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 于感染后第 3 天开始给药,可完全保护 Eimeria tenella 感染雏鸡免于死亡,并减轻其病理损伤,其中 0.05%浓度组的雏鸡体重增幅最高。 Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可对感染 Eimeria necatrix 的雏鸡提供完全的死亡保护并减轻病理损伤,而 0.025%的浓度对该虫种无效。 Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可完全保护感染 Eimeria acervulina 的雏鸡免于死亡,并减轻其病理损伤;其中 0.05%剂量组的雏鸡体重增长水平与未感染对照组相当。 Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可对感染 Eimeria maxima 的雏鸡提供完全的死亡保护,并减轻病理损伤,且所有剂量均能维持相近的体重增长。 Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可对感染 Eimeria brunetti 的雏鸡提供完全的死亡保护,并消除其病理损伤。 Sulfadimethoxine (0.025-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可完全保护感染 Eimeria mivati 的雏鸡免于死亡,并减轻其病理性损伤;其中 0.05%剂量组的雏鸡体重增长高于未感染对照组。 Sulfadimethoxine (0.05%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可对混合 Eimeria 感染的雏鸡提供完全的死亡保护,并减轻其病理损伤。 Sulfadimethoxine (0.0125-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 于感染后第 3 天开始通过饮水给药,可完全保护感染 Eimeria gallopavonis 的火鸡雏鸡免于死亡,并减轻其病理损伤;其中 0.025%剂量组的体重增长优于未感染对照组。 Sulfadimethoxine (0.0125-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 可对感染 Eimeria meleagrimitis 的火鸡雏鸡提供完全的死亡保护,并减轻其病理损伤。 Sulfadimethoxine (0.0125-0.1%;口服给药;每日,连续 6 天) 1000 µg/mL in methanol 于感染后第 3 天开始通过饮水给药,可完全保护感染 Eimeria adenoeides 的雏火鸡免于死亡,并减轻其病理损伤。
| Animal Model: |
Peterson Cross (1 day old, grouped by weight and sex, 2 weeks old at test initiation) |
| Dosage: |
0.025%; 0.05%; 0.1% |
| Administration: |
p.o.; daily; 6 days |
| Result: |
Achieved 0% mortality, 82% weight gain relative to uninfected unmedicated controls (UUC), and average degree of infection (ADI) of 0.3 at 0.1% dose in Eimeria tenella-infected chicks. Achieved 0% mortality, 89% weight gain relative to UUC, and ADI of 0.8 at 0.05% dose in Eimeria tenella-infected chicks. Achieved 0% mortality, 86% weight gain relative to UUC, and ADI of 1.6 at 0.025% dose in Eimeria tenella-infected chicks. Achieved 0% mortality, 71% weight gain relative to UUC, and ADI of 0.7 at 0.1% dose in Eimeria necatrix-infected chicks. Achieved 5% mortality, 60% weight gain relative to UUC, and ADI of 1.9 at 0.05% dose in Eimeria necatrix-infected chicks. Achieved 50% mortality, 39% weight gain relative to UUC, and ADI of 3.4 at 0.025% dose in Eimeria necatrix-infected chicks. Achieved 0% mortality, 86% weight gain relative to UUC, and ADI of 0.3 at 0.1% dose in Eimeria acervulina-infected chicks. Achieved 0% mortality, 101% weight gain relative to UUC, and ADI of 0.3 at 0.05% dose in Eimeria acervulina-infected chicks. Achieved 0% mortality, 92% weight gain relative to UUC, and ADI of 1.6 at 0.025% dose in Eimeria acervulina-infected chicks. Achieved 0% mortality, 83% weight gain relative to UUC, and ADI of 0.5 at 0.1% dose in Eimeria maxima-infected chicks. Achieved 0% mortality, 84% weight gain relative to UUC, and ADI of 0.2 at 0.05% dose in Eimeria maxima-infected chicks. Achieved 0% mortality, 84% weight gain relative to UUC, and ADI of 0.4 at 0.025% dose in Eimeria maxima-infected chicks. Achieved 0% mortality, 80% weight gain relative to UUC, and no detectable lesions at 0.1% dose in Eimeria brunetti-infected chicks. Achieved 0% mortality, 92% weight gain relative to UUC, and no detectable lesions at 0.05% dose in Eimeria brunetti-infected chicks. Achieved 0% mortality, 89% weight gain relative to UUC, and no detectable lesions at 0.025% dose in Eimeria brunetti-infected chicks. Achieved 0% mortality, 86% weight gain relative to UUC, and ADI of 0.0 at 0.1% dose in Eimeria mivati-infected chicks. Achieved 0% mortality, 101% weight gain relative to UUC, and ADI of 0.0 at 0.05% dose in Eimeria mivati-infected chicks. Achieved 0% mortality, 102% weight gain relative to UUC, and ADI of 0.4 at 0.025% dose in Eimeria mivati-infected chicks. |
| Animal Model: |
Peterson Cross (1 day old, grouped by weight and sex, 2 weeks old at test initiation) |
| Dosage: |
0.05% |
| Administration: |
p.o.; daily; 6 days |
| Result: |
Achieved 0% mortality, 90% weight gain relative to UUC, and ADI of 0.3 in chicks with mixed Eimeria infections. |
| Animal Model: |
Broad Breasted White (1 day old, grouped by weight and sex, 2 weeks old at test initiation) |
| Dosage: |
0.0125%; 0.025%; 0.05% |
| Administration: |
p.o.; daily; 6 days |
| Result: |
Achieved 0% mortality, 94% weight gain relative to UUC, and ADI of 0.1 at 0.05% dose in Eimeria gallopavonis-infected turkey poults. Achieved 0% mortality, 101% weight gain relative to UUC, and ADI of 0.0 at 0.025% dose in Eimeria gallopavonis-infected turkey poults. Achieved 0% mortality, 89% weight gain relative to UUC, and ADI of 0.1 at 0.0125% dose in Eimeria gallopavonis-infected turkey poults. Achieved 0% mortality, 77% weight gain relative to UUC, and ADI of 0.0 at 0.05% dose in Eimeria meleagrimitis-infected turkey poults. Achieved 0% mortality, 78% weight gain relative to UUC, and ADI of 0.5 at 0.025% dose in Eimeria meleagrimitis-infected turkey poults. Achieved 0% mortality, 79% weight gain relative to UUC, and ADI of 0.8 at 0.0125% dose in Eimeria meleagrimitis-infected turkey poults. Achieved 0% mortality, 89% weight gain relative to UUC, and ADI of 0.0 at 0.05% dose in Eimeria adenoeides-infected turkey poults. Achieved 0% mortality, 98% weight gain relative to UUC, and ADI of 0.0 at 0.025% dose in Eimeria adenoeides-infected turkey poults. Achieved 0% mortality, 100% weight gain relative to UUC, and ADI of 0.1 at 0.0125% dose in Eimeria adenoeides-infected turkey poults. |
|